Could a simple inhaler prevent deadly pneumonia in ventilator patients?

NCT ID NCT07409727

First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study tests whether inhaling a medicine called N-acetylcysteine (NAC) can prevent pneumonia in critically ill patients who need a breathing machine. About 80 adults on ventilators will receive either NAC or a placebo. Researchers will track how many develop pneumonia and how long it takes, along with other breathing and infection measures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VENTILATION ACQUIRED PNEUMONIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cairo University Hospitals

    RECRUITING

    Cairo, 11011, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.